Lenabasum is new treatment for diffuse cutaneous systemic sclerosis (dcSSc)
Systemic Sclerosis - Bone, Joint, and Muscle Disorders - Merck Manuals Consumer Version
What Is Scleroderma? Symptoms & Causes| NIAMS
Systemic Sclerosis and Scleroderma: Visual Explanation for Students - YouTube
Study Tips: USMLE® Step 1 Question of the Day: Scleroderma
Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need | Nature Reviews Rheumatology
Diffuse Cutaneous Systemic Scleroderma with Secondary Infection: A Case Report
Patient perception of disease burden in diffuse cutaneous systemic sclerosis - Dinesh Khanna, Yannick Allanore, Christopher P Denton, Marco Matucci-Cerinic, Janet Pope, Barbara Hinzmann, Siobhan Davies, Janethe de Oliveira Pena, Oliver Distler,
Scleroderma Guide: Causes, Symptoms and Treatment Options
The nosology of systemic sclerosis: how lessons from the past offer new challenges in reframing an idiopathic rheumatological di
Classification of Scleroderma | Michigan Medicine
Josh Inglis on Twitter: "Diffuse skin involvement is the most important risk factor. Patients with diffuse cutaneous scleroderma* have early internal organ involvement. * purple is affected skin https://t.co/hoCeufuUoE" / Twitter
Skin hardening, but is it systemic sclerosis?
Internal Medicine Interest Group - IMIG - Differentiating Limited Cutaneous Systemic Sclerosis from Diffuse Cutaneous Systemic Sclerosis | Facebook